For decades, discussions comparing Ayurveda and Traditional Chinese Medicine (TCM) have focused on which system is older, which therapies are more effective, or which philosophy is more comprehensive. None of these debates answers the question that really matters. Why has TCM become far more integrated into global healthcare systems while Ayurveda, despite its growing popularity, is still largely viewed as an alternative medicine in many parts of the world? The answer has very little to do with the medicine itself. It has everything to do with the systems built around it. China invested heavily in creating institutions, international partnerships, regulatory standards, research infrastructure, and government-backed healthcare networks that allowed TCM to gain legitimacy across the world. India has made significant progress in promoting Ayurveda internationally, but much of the work is still in its early stages. Ayurveda has never lacked knowledge. What it has lacked is the infrastructure to make that knowledge universally trusted. Understanding this difference is important because it shows that the future of Ayurveda depends not only on preserving ancient knowledge, but also on building modern systems that support it. Traditional Medicine Needs More Than Tradition Many people assume that if a medical system has survived for thousands of years, international recognition will naturally follow. History suggests otherwise. Modern healthcare depends on trust, regulation, education, quality control, and evidence. Governments, insurance providers, hospitals, universities, and regulatory agencies need clear standards before they adopt any healthcare system. This is where China approached TCM differently. Rather than relying solely on the historical significance of traditional medicine, China treated it as a strategic national asset. It invested in making TCM understandable, measurable, teachable, and compatible with modern healthcare systems. That investment continues to shape how TCM is perceived around the world. China Exported Institutions, Not Just Knowledge One of the biggest differences between the two countries lies in how they expanded internationally. China established government-supported Traditional Chinese Medicine centres across multiple countries. They function as real clinical institutions where patients receive treatment, healthcare professionals undergo training, and collaborative medical research takes place. In countries such as Hungary and Thailand, these centers have become long-term healthcare partnerships rather than temporary projects. Chinese physicians regularly rotate through these institutions, local practitioners receive standardized training, and several Chinese herbal medicines have received official regulatory approval within those countries. This creates confidence. Patients know they are entering an institution backed by established systems rather than relying solely on the reputation of an individual practitioner. India has also taken meaningful steps abroad. The Ministry of AYUSH has established AYUSH academic chairs in foreign universities, signed numerous agreements with international governments and educational institutions, and promoted Ayurveda through conferences, educational collaborations, and diplomatic initiatives. These efforts are valuable because they introduce Ayurveda to new audiences and encourage academic interest. However, an academic chair inside a university serves a different purpose from a permanent government-supported healthcare center that treats patients every day. One spreads knowledge, while the other builds healthcare infrastructure. Both matter, but they have very different long-term impacts. Global Standards Build Global Trust Every healthcare system depends on standards. Imagine purchasing an herbal medicine in Germany, Brazil, or Australia. How do regulators determine whether the ingredients meet acceptable quality standards? How does a hospital know whether practitioners received sufficient training? How does a researcher compare results across different countries? Without internationally accepted standards, every country must answer these questions independently. China recognized this challenge early. In 2009, it secured the leadership of ISO Technical Committee 249, the international committee responsible for developing standards for traditional Chinese medicine. Over the years, China has helped develop dozens of international standards covering terminology, herbal materials, medical equipment, testing methods, and quality specifications. These standards make it easier for governments and healthcare institutions worldwide to evaluate and adopt TCM. India entered this process much later. Only in 2025 was a dedicated Ayurveda and Yoga subcommittee established within the same ISO technical committee, following proposals from India’s standards bodies. This development represents an important milestone. It gives Ayurveda a formal opportunity to help shape international standards instead of simply adapting to frameworks created by others. The opportunity now is to actively contribute, develop comprehensive standards, and ensure Ayurveda has a strong voice in global regulatory discussions. Recognition Begins at Home Another major lesson comes from how China positioned TCM within its own healthcare system. Traditional Chinese Medicine practitioners are recognized under the country’s medical framework, and legislation passed in 2017 strengthened the legal standing of TCM institutions alongside conventional medicine. Many treatments are covered through public insurance. Patients encounter TCM within hospitals, specialist clinics, and mainstream healthcare facilities. This domestic integration sends a powerful message internationally. If a country’s own government fully integrates traditional medicine into healthcare delivery, regulators elsewhere become more willing to evaluate it seriously. India has also made substantial progress over the past decade. The Ministry of AYUSH has expanded international collaborations, introduced the AYUSH Visa to encourage medical tourism, established AYUSH Information Cells across numerous countries, and partnered with the World Health Organization to launch the WHO Global Traditional Medicine Centre in Jamnagar. Ayurveda’s inclusion within the WHO’s ICD-11 classification is another significant achievement because it acknowledges traditional medicine within an international health framework. These developments deserve recognition. At the same time, India’s own policy documents acknowledge that further work remains. The NITI Aayog and PwC report Strategic Roadmap for Making Ayurveda Global identifies several continuing challenges, including limited international regulatory harmonization, insufficient evidence-based clinical research, minimal insurance integration, and the need for standardized global education. Recognizing these gaps is not criticism, it is the first step toward solving them. Why Has Acupuncture Become Mainstream? Perhaps the clearest… Continue reading What Ayurveda in India Can Learn from Traditional Chinese Medicine (TCM)